Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Diagnostics In Vitro Diagnostics Clinical Trials

Congenica Tries To Bring Clarity To Personalized Medicine For Rare Diseases

  • Interviews

Executive Summary

Medtech Insight spoke to David Atkins, the CEO of genomics company Congenica, to learn more about how its platform is being used in one of the largest genetics studies to date. The company expects the technology to eventually transform treatment of rare diseases.

You may also be interested in...



Digital Health Roundup: A Season For Interviews, New Frontiers, AI, Cybersecurity

In this roundup feature focusing on developments in digital health, Medtech Insight highlights interviews with Medtronic, Abbott and Congenica, partnerships and launches, and AI and cybersecurity announcements from November.

Execs On The Move: April 2023

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.  

Swedish Drug And Device To Go Head-To-Head In The GERD Space

Two Swedish companies are working on tackling GERD – one with a drug, one with a device.

Table

View full table

Topics

Related Companies

Tags:
Diagnostics In Vitro Diagnostics Clinical Trials
Latest Headlines

News We’re Watching: Medtronic To Buy EOFLow, Neuralink Cleared For Human Trials, NICE Backs Genetic Tests

White House Takes Steps To Advance ‘Responsible’ AI That ‘Upholds Democratic Values’

UK MHRA Says Genetic Biobank Could Transform Drug Safety Monitoring Through Personalized Medicine

Wi-Fi Failures, Custom Tech And Other Challenges Of Bringing Specialty Care Into Patients’ Homes

See All
UsernamePublicRestriction

Register

MT144723

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By